Half-year report · HY
4572.TEDINET S100YV1G
Period2026-01-01 → 2026-06-30
Filed2026-08-07
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 44
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥401m | 2026-01-01 → 2026-06-30 | Cons. | Net sales |
| Revenue | ¥579m | 2025-01-01 → 2025-12-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥251m | 2025-01-01 → 2025-06-30 | Cons. | Net sales |
| Operating income | −¥954m | 2026-01-01 → 2026-06-30 | Cons. | Operating income |
| Operating income | −¥1.1bn | 2025-01-01 → 2025-06-30 | Cons. | Operating income |
| Ordinary income | −¥1.0bn | 2026-01-01 → 2026-06-30 | Cons. | Ordinary income |
| Ordinary income | −¥2.1bn | 2025-01-01 → 2025-12-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | −¥1.1bn | 2025-01-01 → 2025-06-30 | Cons. | Ordinary income |
| Profit before tax | −¥1.0bn | 2026-01-01 → 2026-06-30 | Cons. | Income before income taxes |
| Profit before tax | −¥1.1bn | 2025-01-01 → 2025-06-30 | Cons. | Income before income taxes |
| Net income (owners) | −¥1.0bn | 2026-01-01 → 2026-06-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | −¥2.2bn | 2025-01-01 → 2025-12-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | −¥1.1bn | 2025-01-01 → 2025-06-30 | Cons. | Profit loss attributable to owners of parent |
| Net income | −¥1.0bn | 2026-01-01 → 2026-06-30 | Cons. | Profit loss |
| Net income | −¥1.1bn | 2025-01-01 → 2025-06-30 | Cons. | Profit loss |
| Total assets | ¥1.8bn | at 2026-06-30 | Cons. | Assets |
| Total assets | ¥1.2bn | at 2025-12-31 | Cons. | Assets |
| Total assets | ¥1.6bn | at 2025-06-30 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥2.2bn | at 2026-06-30 | Cons. | Liabilities |
| Total liabilities | ¥920m | at 2025-12-31 | Cons. | Liabilities |
| Net assets / equity | −¥408m | at 2026-06-30 | Cons. | Net assets |
| Net assets / equity | ¥309m | at 2025-12-31 | Cons. | Net assets |
| Net assets / equity | ¥1.4bn | at 2025-06-30 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥1.1bn | at 2026-06-30 | Cons. | Cash and deposits |
| Cash and deposits | ¥517m | at 2025-12-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥1.1bn | at 2026-06-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥517m | at 2025-12-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥1.1bn | at 2025-06-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥2.1bn | at 2024-12-31v | Cons. | Cash and cash equivalents |
| Operating cash flow | −¥915m | 2026-01-01 → 2026-06-30 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | −¥2.2bn | 2025-01-01 → 2025-12-31 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | −¥995m | 2025-01-01 → 2025-06-30 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | −¥11m | 2026-01-01 → 2026-06-30 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥25m | 2025-01-01 → 2025-12-31 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥16m | 2025-01-01 → 2025-06-30 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | ¥1.5bn | 2026-01-01 → 2026-06-30 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | ¥605m | 2025-01-01 → 2025-12-31 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥14m | 2025-01-01 → 2025-06-30 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥-53.13 | 2026-01-01 → 2026-06-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-113.62 | 2025-01-01 → 2025-12-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-55.29 | 2025-01-01 → 2025-06-30 | Cons. | Basic earnings loss per share (5-year summary) |
| Equity ratio | -23.9% | at 2026-06-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 25.1% | at 2025-12-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 85.1% | at 2025-06-30 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 8
| Segment | Item | Period | Value |
|---|---|---|---|
| Drug Discovery Businessreportable segment | segment profit | 2026-01-01 → 2026-06-30 | −¥1.0bn |
| Drug Discovery Support Businessreportable segment | revenue | 2026-01-01 → 2026-06-30 | ¥401m |
| Drug Discovery Support Businessreportable segment | revenue external | 2026-01-01 → 2026-06-30 | ¥401m |
| Drug Discovery Support Businessreportable segment | segment profit | 2026-01-01 → 2026-06-30 | ¥67m |
| Drug Discovery Businessreportable segment | segment profit | 2025-01-01 → 2025-06-30 | −¥1.0bn |
| Drug Discovery Support Businessreportable segment | revenue | 2025-01-01 → 2025-06-30 | ¥251m |
| Drug Discovery Support Businessreportable segment | revenue external | 2025-01-01 → 2025-06-30 | ¥251m |
| Drug Discovery Support Businessreportable segment | segment profit | 2025-01-01 → 2025-06-30 | −¥51m |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 442
| Item | Context | Value | Unit |
|---|---|---|---|
| Number of shares held | InterimInstant_No2MajorShareholdersMember | 597168 | |
| Shareholding ratio | InterimInstant_No2MajorShareholdersMember | 0.0289 | |
| Number of shares held | InterimInstant_No3MajorShareholdersMember | 511500 | |
| Shareholding ratio | InterimInstant_No3MajorShareholdersMember | 0.0247 | |
| Number of shares held | InterimInstant_No4MajorShareholdersMember | 500000 | |
| Shareholding ratio | InterimInstant_No4MajorShareholdersMember | 0.0242 | |
| Number of shares held | InterimInstant_No5MajorShareholdersMember | 500000 | |
| Shareholding ratio | InterimInstant_No5MajorShareholdersMember | 0.0242 | |
| Number of shares held | InterimInstant_No6MajorShareholdersMember | 380100 | |
| Shareholding ratio | InterimInstant_No6MajorShareholdersMember | 0.0184 | |
| Number of shares held | InterimInstant_No7MajorShareholdersMember | 340512 | |
| Shareholding ratio | InterimInstant_No7MajorShareholdersMember | 0.0164 | |
| Number of shares held | InterimInstant_No8MajorShareholdersMember | 320000 | |
| Shareholding ratio | InterimInstant_No8MajorShareholdersMember | 0.0155 | |
| Number of shares held | InterimInstant_No9MajorShareholdersMember | 261000 | |
| Shareholding ratio | InterimInstant_No9MajorShareholdersMember | 0.0126 | |
| Number of shares held | InterimInstant_No10MajorShareholdersMember | 256052 | |
| Shareholding ratio | InterimInstant_No10MajorShareholdersMember | 0.0124 | |
| Number of shares held | InterimInstant | 4279332 | |
| Shareholding ratio | InterimInstant | 0.2073 | |
| Number of shares issued shares voting rights | InterimInstant_SharesWithNoVotingRightsMember | － | |
| Number of shares issued shares voting rights | InterimInstant_SharesWithRestrictedVotingRightsTreasurySharesEtcMember | － | |
| Number of shares issued shares voting rights | InterimInstant_SharesWithRestrictedVotingRightsOtherMember | － | |
| Number of voting rights issued shares voting rights | InterimInstant_SharesWithRestrictedVotingRightsOtherMember | － | |
| Number of shares issued shares voting rights | InterimInstant_OrdinarySharesTreasurySharesSharesWithFullVotingRightsTreasurySharesEtcMember | 11100 | |
| Number of voting rights issued shares voting rights | InterimInstant_OrdinarySharesSharesWithFullVotingRightsOtherMember | 206315 | |
| Number of shares issued shares voting rights | InterimInstant_OrdinarySharesSharesWithFullVotingRightsOtherMember | 20631500 | |
| Number of shares issued shares voting rights | InterimInstant_OrdinarySharesSharesLessThanOneUnitMember | 9869 | |
| Number of shares issued shares voting rights | InterimInstant | 20652469 | |
| Number of voting rights issued shares voting rights | InterimInstant | 206315 | |
| Number of shares held in own name treasury shares etc | InterimInstant_Row1Member | 11100 | |
| Number of shares held in others names treasury shares etc | InterimInstant_Row1Member | － | |
| Total number of shares held treasury shares etc | InterimInstant_Row1Member | 11100 | |
| Shareholding ratio treasury shares etc | InterimInstant_Row1Member | 0.0005 | |
| Number of shares held in own name treasury shares etc | InterimInstant | 11100 | |
| Number of shares held in others names treasury shares etc | InterimInstant | － | |
| Total number of shares held treasury shares etc | InterimInstant | 11100 | |
| Shareholding ratio treasury shares etc | InterimInstant | 0.0005 | |
| Cash and deposits | Prior1YearInstant | 516789000 | JPY |
| Cash and deposits | InterimInstant | 1100479000 | JPY |
| Accounts receivable trade | Prior1YearInstant | 100528000 | JPY |
| Accounts receivable trade | InterimInstant | 116403000 | JPY |
| Merchandise and finished goods | Prior1YearInstant | 106302000 | JPY |
| Merchandise and finished goods | InterimInstant | 103747000 | JPY |
| Work in process | Prior1YearInstant | 11609000 | JPY |
| Work in process | InterimInstant | 11486000 | JPY |
| Raw materials and supplies | Prior1YearInstant | 36190000 | JPY |
| Raw materials and supplies | InterimInstant | 34899000 | JPY |
| Advance payments trade | Prior1YearInstant | 261308000 | JPY |
| Advance payments trade | InterimInstant | 264530000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 14 of 14 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |